AMENDMENT NO. 1 to AMENDED AND RESTATED GOVERNANCE AGREEMENTGovernance Agreement • May 21st, 1999 • American Home Products Corp • Pharmaceutical preparations
Contract Type FiledMay 21st, 1999 Company Industry
IMMUNEX CORPORATION 3% Convertible Subordinated Note due 2006 NOTE PURCHASE AGREEMENT Dated as of May 20, 1999 Immunex Corporation 51 University Street Seattle, Washington 98101Note Purchase Agreement • May 21st, 1999 • American Home Products Corp • Pharmaceutical preparations • New York
Contract Type FiledMay 21st, 1999 Company Industry Jurisdiction
THE NOTE EVIDENCED HEREBY HAS NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY STATE SECURITIES LAWS, AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES OR TO, OR FOR THE ACCOUNT...Note Purchase Agreement • May 21st, 1999 • American Home Products Corp • Pharmaceutical preparations
Contract Type FiledMay 21st, 1999 Company IndustryTHE NOTE EVIDENCED HEREBY HAS NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY STATE SECURITIES LAWS, AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS EXCEPT AS SET FORTH IN THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF, THE HOLDER (1) REPRESENTS THAT (A) IT IS A "QUALIFIED INSTITUTIONAL BUYER" (AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT) OR (B) IT IS AN INSTITUTIONAL "ACCREDITED INVESTOR" (AS DEFINED IN RULE 501(A)(1), (2), (3) OR (7) UNDER THE SECURITIES ACT) ("INSTITUTIONAL ACCREDITED INVESTOR"); (2) AGREES THAT IT WILL NOT, PRIOR TO EXPIRATION OF THE HOLDING PERIOD APPLICABLE TO SALES OF THE NOTE EVIDENCED HEREBY UNDER RULE 144 UNDER THE SECURITIES ACT (OR ANY SUCCESSOR PROVISION), RESELL OR OTHERWISE TRANSFER THE NOTE EVIDENCED HEREBY OR THE COMMON STOCK ISSUABLE UPON CONVERSION OF SUCH NOTE EXCEPT (A) TO IMMUNEX CORPORATION OR ANY SUBSIDIARY THE